Tengjun Biotechnology Revenue Growth Rates (CHGH), Current and Historic Growth - CSIMarket
CSIMarket
 


Tengjun Biotechnology Corp   (CHGH)
 

CHGH's Revenue Growth by Quarter and Year

Tengjun Biotechnology 's Revenue results by quarter and year




CHGH Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.00
1st Quarter March 8.52
FY 8.52





CHGH Revenue second quarter 2023 Y/Y Growth Comment
Tengjun Biotechnology Corp in the second quarter 2023 recorded of $ 0.00 millions.

Looking into second quarter 2023 results within Nonalcoholic Beverages industry 12 other companies have achieved higher Revenue growth. While Tengjun Biotechnology Corp ' s Revenue meltdown of -100% ranks overall at the positon no. 2005 in the second quarter 2023.




CHGH Revenue ( Y/Y Growth %) 2023
2022 2021 2020
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March 99.07 % - - -
FY   - - - -

Financial Statements
Tengjun Biotechnology 's second quarter 2023 Revenue $ 0.00 millions CHGH's Income Statement
Tengjun Biotechnology 's second quarter 2022 Revenue $ 51.29 millions Quarterly CHGH's Income Statement


CHGH Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
4th Quarter December - 59.64 % - -
3rd Quarter September - -28.99 % - -
2nd Quarter June - 1098.36 % - -
1st Quarter March -85.35 % - - -
FY (Year on Year)   - - - -




Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #13
Consumer Non Cyclical Sector #69
Overall #2005

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #13
Consumer Non Cyclical Sector #69
Overall #2005
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Tengjun Biotechnology 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CHGH's II. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Tengjun Biotechnology Corp come out even worse considering the 8.52 millions a quarter before.

Within Nonalcoholic Beverages industry Tengjun Biotechnology Corp achieved highest sequential Revenue growth. While Tengjun Biotechnology 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CHGH's II. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Tengjun Biotechnology Corp come out even worse considering the 8.52 millions a quarter before.

Within Nonalcoholic Beverages industry Tengjun Biotechnology Corp achieved highest sequential Revenue growth. While Tengjun Biotechnology 's Revenue growth quarter on quarter, overall rank is .


Tengjun Biotechnology 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 0.00 $ 154.37 $ 150.14 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - 2.82 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 2470 # 2075 # 0 # 0 # 0


Cumulative Revenue growth Comment
In the Jun 30 2023 period, Tengjun Biotechnology 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Tengjun Biotechnology Corp achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 95
S&P 500 # 2470
Cumulative Revenue growth Comment
In the Jun 30 2023 period, Tengjun Biotechnology 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Tengjun Biotechnology Corp achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 95
S&P 500 # 2470




Other Revenue Growth
Nonalcoholic Beverages Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CHGH's Revenue Growth Ratio versus Nonalcoholic Beverages Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue meltdown for the quarter ending Jun 30 2023 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Whole Earth Brands Inc -0.84%$ -0.841 millions
Im Cannabis Corp -1.19%$ -1.194 millions
Benson Hill Inc -1.61%$ -1.606 millions
The Hain Celestial Group Inc -2.01%$ -2.006 millions
China Green Agriculture Inc-2.16%$ -2.157 millions
Crimson Wine Group Ltd -2.68%$ -2.682 millions
4front Ventures Corp -4.44%$ -4.445 millions
Cronos Group Inc -5.35%$ -5.347 millions
Vector Group Ltd-5.56%$ -5.563 millions
Mannatech Inc-6.82%$ -6.822 millions
Village Farms International Inc -6.86%$ -6.865 millions
Pilgrim s Pride Corporation-6.99%$ -6.986 millions
Zevia Pbc-7.25%$ -7.248 millions
Archer daniels midland Co-7.67%$ -7.675 millions
Legend Spices Inc -7.69%$ -7.692 millions
Jushi Holdings Inc.-8.70%$ -8.703 millions
Sanfilippo John B and Son Inc-9.13%$ -9.128 millions
Andersons Inc -9.67%$ -9.671 millions
Trulieve Cannabis Corp.-10.21%$ -10.210 millions
American Vanguard Corporation-10.92%$ -10.923 millions
Cirtran Corporation-12.98%$ -12.983 millions
Panacea Life Sciences Holdings Inc -14.98%$ -14.984 millions
Bunge Global Sa-16.08%$ -16.082 millions
Eos Inc -16.84%$ -16.843 millions
Jones Soda Co -20.10%$ -20.100 millions
Laird Superfood Inc -20.73%$ -20.728 millions
Kona Gold Beverage Inc -20.78%$ -20.784 millions
Natural Health Trends Corp -21.32%$ -21.325 millions
Golden Growers Cooperative-21.99%$ -21.994 millions
Vintage Wine Estates Inc -22.59%$ -22.588 millions


About Tengjun Biotechnology Revenue Growth Rates (CHGH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Tengjun Biotechnology Corp (CIK 1499785).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-23-067340
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Tengjun Biotechnology Corp ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.